RI
TSHA icon

RTW Investments’s Taysha Gene Therapies TSHA Stock Holding History

RTW Investments’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.3M Sell
13,560,258
-119,990
-0.9% -$710K 0.79% 35
2026
Q1 		$61.2M Sell
13,680,248
-2,718,049
-17% -$12.6M 0.61% 40
2025
Q4 		$90.2M Sell
16,398,297
-7,955,994
-33% -$38.6M 0.9% 30
2025
Q3 		$79.6M Sell
24,354,291
-667,293
-3% -$1.89M 0.98% 29
2025
Q2 		$57.8M Buy
25,021,584
+6,233,718
+33% +$13.5M 0.82% 33
2025
Q1 		$26.1M Buy
18,787,866
+10,115,236
+117% +$16.9M 0.4% 38
2024
Q4 		$15M Sell
8,672,630
-6,273,790
-42% -$13M 0.23% 49
2024
Q3 		$30M Sell
14,946,420
-3,853,879
-20% -$8.46M 0.43% 40
2024
Q2 		$42.1M Buy
18,800,299
+207,114
+1% +$603K 0.65% 37
2024
Q1 		$53.4M Buy
18,593,185
+1,700,000
+10% +$3.54M 0.79% 38
2023
Q4 		$29.9M Hold
16,893,185
– – 0.47% 36
2023
Q3 		$53.4M Buy
+16,893,185
New +$31.6M 1.13% 23

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

RTW Investments's TSHA Position: Q2 2026 in Review

RTW Investments reduced its Taysha Gene Therapies (TSHA) stake by 0.88% in Q2 2026, selling an estimated $710K and leaving 13,560,258 shares worth $92.3M. The position accounts for 0.79% of the portfolio, ranked #35.

RTW Investments first reported a position in TSHA in Q3 2023 and has held it in 12 quarters since. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • RTW Investments held 13,560,258 shares of Taysha Gene Therapies worth $92.3M as of Q2 2026.
  • RTW Investments sold 119,990 Taysha Gene Therapies shares in Q2 2026, an estimated $710K.
  • Taysha Gene Therapies made up 0.79% of RTW Investments's portfolio in Q2 2026, its #35 holding.
  • RTW Investments first reported a position in Taysha Gene Therapies in Q3 2023 and has held it in 12 quarters since.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.